Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. It is also being studied for other types of cancer. It has been used for Albright syndrome. Tamoxifen is typically taken daily by mouth for five years for breast cancer.
Read the full article on WikipediaReduction of breast cancer risk Clinical criteria: Patient must have a moderate or high risk of developing breast cancer, AND The treatment must not exceed a dose of 20 mg per day, AND The treatment must not exceed a lifetime maximum of 5 years for this condition. Treatment criteria: Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
Breast cancer Clinical criteria: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient, AND The condition must be hormone receptor positive.
“5–7 days”
Working under the parallel aged-care framework? Aged-care equivalent →